Korro Bio, Inc.
KRRO
$10.18
-$0.90-8.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.84M | 6.39M | 7.37M | 6.28M | 4.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.84M | 6.39M | 7.37M | 6.28M | 4.82M |
| Cost of Revenue | 49.24M | 55.13M | 60.71M | 62.54M | 58.46M |
| Gross Profit | -45.40M | -48.74M | -53.34M | -56.25M | -53.64M |
| SG&A Expenses | 37.36M | 38.60M | 41.16M | 42.30M | 41.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 86.60M | 93.73M | 101.87M | 104.84M | 100.30M |
| Operating Income | -82.76M | -87.34M | -94.50M | -98.55M | -95.48M |
| Income Before Tax | -112.77M | -116.62M | -88.31M | -91.26M | -87.29M |
| Income Tax Expenses | 732.00K | 637.00K | 104.00K | 95.00K | 124.00K |
| Earnings from Continuing Operations | -113.50 | -117.26 | -88.42 | -91.36 | -87.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -113.50M | -117.26M | -88.42M | -91.36M | -87.41M |
| EBIT | -82.76M | -87.34M | -94.50M | -98.55M | -95.48M |
| EBITDA | -79.32M | -83.06M | -89.62M | -93.98M | -91.41M |
| EPS Basic | -11.67 | -12.47 | -9.42 | -9.76 | -9.44 |
| Normalized Basic EPS | -4.96 | -5.46 | -5.88 | -6.09 | -5.89 |
| EPS Diluted | -11.67 | -12.47 | -9.42 | -9.76 | -9.44 |
| Normalized Diluted EPS | -4.96 | -5.46 | -5.88 | -6.09 | -5.89 |
| Average Basic Shares Outstanding | 39.80M | 37.58M | 37.53M | 37.45M | 37.04M |
| Average Diluted Shares Outstanding | 39.80M | 37.58M | 37.53M | 37.45M | 37.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |